Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

SEC filing history

Showing 851-875 of 958 matching filings.

Per page
25
Current page
35
4

2011 SPECIAL INCENTIVE OPTION

Filing date
25 Aug 2011
Reporting date
24 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

2011 SPECIAL INCENTIVE OPTION

Filing date
25 Aug 2011
Reporting date
24 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

2011 SPECIAL INCENTIVE OPTION

Filing date
25 Aug 2011
Reporting date
24 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK PURCHASE 8.25.2011

Filing date
25 Aug 2011
Reporting date
25 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
11 Aug 2011
Reporting date
11 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OCLASSEN AUG 2011 PURCHASE

Filing date
11 Aug 2011
Reporting date
10 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81821

SCHEDULE 13D AMENDMENT NO. 1

Filing date
22 Jul 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Jul 2011
Reporting date
18 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
18 Jul 2011
Reporting date
12 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Jul 2011
Reporting date
13 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
24 Jun 2011
Reporting date
23 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

10B5-1 SALES - JUNE 2011

Filing date
15 Jun 2011
Reporting date
15 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
27 May 2011
Reporting date
26 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
24 May 2011
Reporting date
24 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-51967

FORM 10-Q

Filing date
16 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
16 May 2011
Reporting date
16 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
16 May 2011
Reporting date
14 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-51967

DEFINITIVE PROXY STATEMENT

Filing date
29 Apr 2011
Reporting date
23 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-51967

FORM 10-K

Filing date
30 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MONTREUX Q1 2011 SALES

Filing date
30 Mar 2011
Reporting date
29 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
16 Mar 2011
Reporting date
14 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

10B5-1 SALES - MARCH 2011

Filing date
16 Mar 2011
Reporting date
15 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
07 Feb 2011
Reporting date
02 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81821

SC 13G/A

Filing date
04 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .